SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-045272
Filing Date
2023-12-18
Accepted
2023-12-18 16:15:26
Documents
12
Period of Report
2023-12-18
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 36579
  Complete submission text file 0001493152-23-045272.txt   205834

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE rnxt-20231218.xsd EX-101.SCH 3015
3 XBRL LABEL FILE rnxt-20231218_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE rnxt-20231218_pre.xml EX-101.PRE 22359
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3121
Mailing Address 333 W. SANTA CLARA STREET, SUITE 900 SAN JOSE CA 95110
Business Address 333 W. SANTA CLARA STREET, SUITE 900 SAN JOSE CA 95110 408-800-2649
RenovoRx, Inc. (Filer) CIK: 0001574094 (see all company filings)

IRS No.: 271448452 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40738 | Film No.: 231493906
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)